PAREXEL International Given New $42.00 Price Target at Sterne Agee (PRXL)
Research analysts at Sterne Agee lifted their price objective on shares of PAREXEL International (NASDAQ:PRXL) from $36.00 to $42.00 in a report released on Friday. Sterne Agee’s target price would suggest a potential downside of 25.24% from the company’s current price.
A number of other analysts have also recently weighed in on PRXL. Analysts at Robert W. Baird raised their price target on shares of PAREXEL International from $64.00 to $66.00 in a research note on Thursday. They now have an “outperform” rating on the stock. Separately, analysts at Jefferies Group raised their price target on shares of PAREXEL International from $58.00 to $59.00 in a research note on Thursday. They now have a “hold” rating on the stock. Finally, analysts at KeyCorp initiated coverage on shares of PAREXEL International in a research note on Wednesday, July 2nd. They set a “hold” rating on the stock. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $56.63.
Shares of PAREXEL International (NASDAQ:PRXL) traded up 0.73% during mid-day trading on Friday, hitting $56.20. 776,376 shares of the company’s stock traded hands. PAREXEL International has a 52 week low of $37.53 and a 52 week high of $57.25. The stock’s 50-day moving average is $53.98 and its 200-day moving average is $51.74. The company has a market cap of $3.196 billion and a P/E ratio of 24.80.
PAREXEL International (NASDAQ:PRXL) last announced its earnings results on Thursday, August 7th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.03. The company had revenue of $510.60 million for the quarter, compared to the consensus estimate of $508.99 million. During the same quarter in the previous year, the company posted $0.50 earnings per share. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. On average, analysts predict that PAREXEL International will post $2.68 earnings per share for the current fiscal year.
PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.
Receive News & Ratings for PAREXEL International Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Co and related companies with Analyst Ratings Network's FREE daily email newsletter.